Page last updated on April 11, 2024
Lexeo Therapeutics, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-11 09:29:19 EDT.
Filings
10-K filed on 2024-03-11
Lexeo Therapeutics, Inc. filed an 10-K at 2024-03-11 09:29:19 EDT
Accession Number: 0000950170-24-028941
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Company Information
| Name | Lexeo Therapeutics, Inc. |
| CIK | 0001907108 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Ticker | LXEO - Nasdaq |
| Website | |
| Category | Non-accelerated filer Smaller reporting company Emerging growth company |
| Fiscal Year End | December 30 |